What is European Biotech Acquisition Corp. (EBAC)?

European Biotech Acquisition Corp. (EBAC) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of EBAC?

The current price of EBAC is $11.19. Prices are updated in real time on Stocks360.

What is EBAC's price-to-earnings (PE) ratio?

EBAC's trailing twelve-month PE ratio is 41.44, based on current price and earnings per share data available on Stocks360.

What is EBAC's market capitalization?

EBAC's market capitalization is $183,500,312.00, placing it in the small-cap tier.

European Biotech Acquisition Corp. (EBAC)

Stock analysis · NASDAQ · Financial Services · Shell Companies

$11.19

Market Cap

$183.50M

PE (TTM)

41.44

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.00

Day Range

$10.55 – $11.69

52-wk Range

$9.28 – $14.10

Avg Volume

N/A

Volume

77.64K

European Biotech Acquisition Corp. (EBAC) is a publicly traded company in the Financial Services sector. Latest price: $11.19. Market cap $183.50M. Trailing PE 41.44. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About European Biotech Acquisition Corp.

European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	41.44×
P/S (TTM)	0.00×
P/B	1.18×
P/FCF (TTM)	-356.46×
EV / EBITDA	0.00×
EV / Sales	0.00×
Earnings Yield	2.46%
Free Cash Flow Yield	-0.28%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$183.19M
Net Income (TTM)	$4.50M
Free Cash Flow (TTM)	-$514.79K
Net Debt	-$308.49K
Working Capital	-$438.93K
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	2.90%
Return on Invested Capital	-2.19%